Samuel O'Brient

Samuel O'Brient

Expertise: Global Financial Markets, Macroeconomics and Geopolitics

Education: BA, Economics & Political Science, Sarah Lawrence College; MSc, International Politics, Trinity College Dublin

Awards & Accomplishments: Published in Curlew Quarterly. Quoted in Forbes. Interviewed by Foreign Policy.

About Samuel
Samuel O’Brient is a Reporter for InvestorPlace, where his work focuses primarily on financial markets, global economic trends, and public policy. O’Brient writes a weekly column on recent political news that investors should be following.

From his early days at InvestorPlace, O’Brient found himself drawn to the booming world of electric vehicles and green energy. His coverage of mining and other battery components has made him an expert source for industry publications. During his early years as an Economic Policy Analyst at U.S. Resist News, he gained expertise in international trade as the U.S.-China trade war dominated headlines. This in-depth research and analysis experience helped strengthen his prowess in all things political economy. O’Brient brings this expertise to work with him every day, thoughtfully analyzing how the daily happenings on the Capitol trickle down to Wall Street… and how retail investors can take action to profit.

An experienced journalist, editor, and economic policy analyst, O’Brient has spent his career guided by a deep passion for economic theory and policy. As a financial blogger on TipRanks, he has received 4.6 stars and is ranked in the top 10% of stock pickers.

O’Brient’s work on economic and tech policy has been curated by popular outlets Marker, OneZero and Gen.

He can be reached on LinkedIn and Muck Rack.

Recent Articles

Tesla Stock: Recent Self-Driving Success Promises a Smooth Road Ahead

Tesla stock has had a difficult month but its self-driving tech progress may keep it in the running, despite questionable 2022 forecast.

MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?

Vaccine stocks aren't enjoying a good morning today, but there's plenty of reason to suspect that they are in for a better year in 2022.

OCGN Stock Alert: What Is Going on With Ocugen Today?

OCGN stock has been on a turbulent ride this morning following updates from Ocugen's partner Bharat Biotech. Here's what to know.

GME Stock Alert: What Is Going on With GameStop Today?

The release of Spider-Man: No Way Home has both AMC and GME stock shooting up as fans flock back to the theater. Here's why it matters.

Want to Bet Against Cathie Wood Stocks in 2022? Consider the SARK ETF.

The SARK ETF seeks to give investors a way to short sell Cathie Wood's flagship fund. Here's what you should know about the new offering.